Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ‘t Veer, Ella F. Jones et al.|Breast Cancer Research|2017Cited by 24
Abstract P6-11-02: Spatial distribution of veliparib measured by matrix assisted laser desorption ionization mass spectrometry in triple negative breast cancer tumorsImke H. Bartelink, Laura van ‘t Veer, Brendan Prideaux et al.|Cancer Research|2015Cited by 0
Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumorsImke H. Bartelink, Laura van'tVeer, Brendan Prideaux et al.|Molecular Cancer Therapeutics|2015Cited by 0
Additional file 1: of Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ât Veer, Brendan Prideaux et al.|Figshare|2017Cited by 0
Additional file 1: of Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ât Veer, Brendan Prideaux et al.|Figshare|2017Cited by 0